WRBY Warby Parker Inc.
Updated
Warby Parker Inc. (WRBY) is a healthcare company in the Ophthalmic Goods industry, with a market capitalization of $2.9 billion. Shares last traded at $23.29, 24.9% below their 52-week high. Over the past year the stock is down 7.8%. WRBY trades at a price-to-earnings ratio of 372.01, above the Ophthalmic Goods median of 167.20. Net profit margin is 0.8%, below the peer median of 1.1%. Revenue grew 13.0% year over year.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $0.06 | 2026-08-06 |
| Q1 2026 | $0.03 | 2026-05-07 |
| FY 2025 | $0.01 | 2026-02-26 |
| Q3 2025 | $0.06 | 2025-11-06 |
| Q2 2026 | $0.01 | 2026-08-06 |
| Q1 2026 | $0.03 | 2026-05-07 |
Ophthalmic Goods peers
WRBY vs 9 industry peers (Ophthalmic Goods), by market cap. Updated
| COO | Cooper Companies (The) | $13.4B | 23.55 | 3.17 | 13.5% | +1.31% |
| BLCO | Bausch & Lomb Corp | $6.5B | -37.89 | 1.22 | -3.2% | +0.72% |
| WRBY | Warby Parker Inc. | $2.9B | 372.01 | 3.16 | 0.8% | -2.65% |
| EYE | National Vision Holdings, Inc. | $1.3B | 26.53 | 0.66 | 2.5% | +0.42% |
| STAA | Staar Surgical Co | $1.2B | 307.86 | 3.48 | 1.1% | +1.90% |
| RXST | Rxsight, Inc. | $272M | -5.79 | 2.24 | -38.8% | -7.24% |
| LUCY | Innovative Eyewear Inc | $8M | -1.02 | — | — | -2.08% |
| ALC | Alcon Inc | — | — | — | 30.8% | -0.21% |
| LUCYW | Innovative Eyewear Inc | — | — | — | — | -2.96% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.